Filing Details

Accession Number:
0001019687-10-000261
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-21 12:00:00
Reporting Period:
2010-01-19
Filing Date:
2010-01-21
Accepted Time:
2010-01-21 20:33:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1282393 Bioform Medical Inc BFRM Surgical & Medical Instruments & Apparatus (3841) 391979642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227036 Biotechnology Development Fund Iv Lp 575 High Street, Suite 201
Palo Alto, CA 94301
No No Yes No
1261786 Bioasia Investments Iv Llc 575 High Street, Suite 201
Palo Alto, CA 94301
No No Yes No
1416946 Bioasia Crossover Fund Lp 575 High Street, Suite 201
Palo Alto, CA 94301
No No Yes No
1417304 Biotechnology Development Fund Iv Affiliates Lp 575 High Street, Suite 201
Palo Alto, CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-19 3,669 $5.51 22,347 No 4 S Indirect By Biotechnology Development Fund IV Affiliates, L.P.
Common Stock Disposition 2010-01-19 198,487 $5.51 1,209,057 No 4 S Indirect By Biotechnology Development Fund IV, L.P.
Common Stock Disposition 2010-01-19 58,182 $5.51 354,406 No 4 S Indirect By BioAsia Crossover Fund, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Biotechnology Development Fund IV Affiliates, L.P.
No 4 S Indirect By Biotechnology Development Fund IV, L.P.
No 4 S Indirect By BioAsia Crossover Fund, L.P.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The reported securities are owned directly by Biotechnology Development Fund IV Affiliates, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV Affiliates, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
  3. The reported securities are owned directly by Biotechnology Development Fund IV, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of Biotechnology Development Fund IV, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
  4. The reported securities are owned directly by BioAsia Crossover Fund, L.P. and indirectly by BioAsia Investments IV, LLC, as general partner of BioAsia Crossover Fund, L.P. BioAsia Investments IV, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.